HSIT.F logo

HBL - Hadasit Bio-Holdings OTCPK:HSIT.F Stock Report

Last Price

US$0.25

Market Cap

US$1.7m

7D

0%

1Y

n/a

Updated

11 Nov, 2023

Data

Company Financials

HBL - Hadasit Bio-Holdings Ltd

OTCPK:HSIT.F Stock Report

Market Cap: US$1.7m

HSIT.F Stock Overview

HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel.

HSIT.F fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

HBL - Hadasit Bio-Holdings Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HBL - Hadasit Bio-Holdings
Historical stock prices
Current Share Price₪0.25
52 Week High₪0.35
52 Week Low₪0.0003
Beta0.78
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-87.15%
5 Year Changen/a
Change since IPO-83.87%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

HSIT.FUS BiotechsUS Market
7D0%-0.5%0.6%
1Yn/a9.6%29.5%

Return vs Industry: Insufficient data to determine how HSIT.F performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how HSIT.F performed against the US Market.

Price Volatility

Is HSIT.F's price volatile compared to industry and market?
HSIT.F volatility
HSIT.F Average Weekly Movementn/a
Biotechs Industry Average Movement11.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: HSIT.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine HSIT.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20052Yoram Azulaihttps://www.hbl.co.il

HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer.

HBL - Hadasit Bio-Holdings Ltd Fundamentals Summary

How do HBL - Hadasit Bio-Holdings's earnings and revenue compare to its market cap?
HSIT.F fundamental statistics
Market capUS$1.75m
Earnings (TTM)-US$7.59m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HSIT.F income statement (TTM)
Revenue₪0
Cost of Revenue₪0
Gross Profit₪0
Other Expenses₪29.30m
Earnings-₪29.30m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.64
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio29.3%

How did HSIT.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.